Lineage Cell Therapeutics, Inc. Annual Operating Margin in % from 2010 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2010 to 2023.
  • Lineage Cell Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -414 %, a 84.9% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Operating Margin for 2023 was -277 %, a 80.5% decline from 2022.
  • Lineage Cell Therapeutics, Inc. annual Operating Margin for 2022 was -153 %, a 86.5% increase from 2021.
  • Lineage Cell Therapeutics, Inc. annual Operating Margin for 2021 was -1.13K %, a 21.7% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -277 -123 -80.5% Jan 1, 2023 Dec 31, 2023
2022 -153 +980 +86.5% Jan 1, 2022 Dec 31, 2022
2021 -1.13K +315 +21.7% Jan 1, 2021 Dec 31, 2021
2020 -1.45K Jan 1, 2020 Dec 31, 2020
2015 -935 +31.2 +3.22% Jan 1, 2015 Dec 31, 2015
2014 -966 +296 +23.5% Jan 1, 2014 Dec 31, 2014
2013 -1.26K -624 -97.7% Jan 1, 2013 Dec 31, 2013
2012 -639 -217 -51.5% Jan 1, 2012 Dec 31, 2012
2011 -421 -156 -58.6% Jan 1, 2011 Dec 31, 2011
2010 -266 Jan 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.